NEW: Coronavirus (COVID-19)
On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic. Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is thought to spread from person to person in close contact through respiratory droplets.
During these unprecedented times, Anchor BioResearch is poised and ready to provide critical results and information to frontline healthcare providers, patients, and medical facilities. We will be offering COVID-19 testing that is imperative in aiding healthcare provider to identify infected patients accurately and quickly.
Serology: Serological tests measure the amount of antibodies or proteins present in the blood when the body is responding to a specific infection, like COVID-19. The test detects the body’s immune response to the infection caused by the virus rather than detecting the virus itself. Test will help healthcare professionals to identify individuals who have overcome an infection in the past and have developed an immune response.
Molecular: Molecular tests are intended for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal swabs from individuals suspected of COVID-19. Real-time reverse-transcription polymerase chain reaction (rRT-PCR) assays are used to detect viral RNA in clinical samples and will help healthcare professionals identify individuals who have an active infection.
Anchor BioResearch is committed to ensuring that patients and their healthcare providers have access to COVID-19 testing to promote earlier diagnosis and help limit spread of infection.